JANX icon

Janux Therapeutics

49 hedge funds and large institutions have $388M invested in Janux Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$23.9M
2 +$5.63M
3 +$1.52M
4
Morgan Stanley
Morgan Stanley
New York
+$1.52M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.48M

Top Sellers

1 -$601K
2 -$395K
3 -$138K
4
N
Nuveen
North Carolina
-$26.7K
5
Goldman Sachs
Goldman Sachs
New York
-$24.3K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$117M
2
$84.6M
3
$53.1M
4
$25.1M
5
$19.9M
6
$19.2M
7
$16.9M
8
$10.3M
9
$6.04M
10
$5.42M
11
$5.42M
12
$4.88M
13
$4.53M
14
$3.58M
15
$1.92M
16
$1.85M
17
$1.43M
18
$1.42M
19
$987K
20
$679K
21
$669K
22
$631K
23
$452K
24
$346K
25
$206K